现在股价处在低位，基_老虎社区_美港股上老虎 - 老虎社区

现在股价处在低位，基本面没变差，熬一阵等医药风口轮过来就行$迈威生物-B(02493)$

@徐君论财：精彩回顾 | 价值致远，聚势赋能——迈威生物第九届科技大会

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":571155827302928,"tweetId":"571155827302928","gmtCreate":1780466523487,"gmtModify":1780467849091,"author":{"id":4130588704550290,"idStr":"4130588704550290","authorId":4130588704550290,"authorIdStr":"4130588704550290","name":"春来春往","avatar":"https://static.tigerbbs.com/c7437b6d6248976f55420f5dcd4590a2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body>现在股价处在低位，基本面没变差，熬一阵等医药风口轮过来就行<a target=\"_blank\" href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$ </a>\n<br></body></html>","htmlText":"<html><head></head><body>现在股价处在低位，基本面没变差，熬一阵等医药风口轮过来就行<a target=\"_blank\" href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$ </a>\n<br></body></html>","text":"现在股价处在低位，基本面没变差，熬一阵等医药风口轮过来就行$迈威生物-B(02493)$","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/571155827302928","repostId":570521772691696,"repostType":1,"repost":{"magic":2,"id":570521772691696,"tweetId":"570521772691696","gmtCreate":1780291743801,"gmtModify":1780291880419,"author":{"id":4187155108895600,"idStr":"4187155108895600","authorId":4187155108895600,"authorIdStr":"4187155108895600","name":"徐君论财","avatar":"https://static.tigerbbs.com/35164f7402825e8ea0e34ee9f6b5ae24","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.05.21","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"wearingBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[{"themeId":"db24b339c29c488488c3af04b083adb3","categoryId":"b76d3c59fc044df59779c041b25852a6","name":"投资心得：大家最近交易顺不顺？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":db24b339c29c488488c3af04b083adb3}&rnconfig={\"headerBarHidden\": true}","description":"金&银暴涨、存储暴涨、科技巨头承压……最近各位小虎们投资还顺利吗？如果不断在踏错、卖飞，你有何建议？","image":"https://static.tigerbbs.com/aac5a419175ce686bf9961052681b214"}],"images":[{"img":"https://static.tigerbbs.com/5afe7e68fada14688c09394f57c08aca","width":"1080","height":"720"},{"img":"https://static.tigerbbs.com/4b68c55348fcbe2bd3055929a35cea11","width":"1080","height":"720"}],"coverImages":[{"img":"https://static.tigerbbs.com/5afe7e68fada14688c09394f57c08aca","width":"1080","height":"720"}],"title":"精彩回顾 | 价值致远，聚势赋能——迈威生物第九届科技大会","html":"<html><head></head><body><p>迈威生物董事长、CEO 刘大涛博士首先回顾了公司过去一年取得的成果，从创新研发、资本、商业化等多个维度分析了行业现状，并对迈威生物的发展提出了更高的要求。他强调，<strong>创新药的价值是临床获益、创新突破与全球竞争力的综合体现，同时兼顾经济效率与公共价值</strong>。迈威生物聚焦兼具临床价值与商业价值的创新研发，持续跟踪和参与基础研究前沿，在深刻理解疾病生物学机制的前提下，重点布局具备 First in class 潜力的品种，并实现从学术到工业的创新转化。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5afe7e68fada14688c09394f57c08aca\" tg-width=\"1080\" tg-height=\"720\"></p>\n<p>随后，各团队骨干围绕“价值致远，聚势赋能”的主题，通过追踪行业前沿动态与政策导向、复盘项目实践得失，分享了对创新药研发、产品成果转化和商业化的深刻思考，为公司的未来发展提供了建设性思路。今年，大会新增了 AI 论坛，邀请内外部讲者分享了 AI 在药物开发中的实践案例，并展望 AI 在生物药研发领域广阔前景。大会最后对在知识产权、成果转化、融资及上市项目中做出突出贡献的团队和个人进行了表彰。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4b68c55348fcbe2bd3055929a35cea11\" tg-width=\"1080\" tg-height=\"720\"></p>\n<p>科技大会是迈威生物为推动新药研发及商业转化体系建设、赋能核心骨干，持续提升创新管理水平的年度交流大会。大会促进跨部门经验共享、视野互通，赋能全链条效率提升，为业务创新优化提效提供了全新参考方向。迈威生物始终致力于源头创新，专注于肿瘤与年龄相关性疾病领域，让创新成果切实惠及患者，满足全球更多未被满足的临床需求。</p>\n<p><a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a></p></body></html>","htmlText":"<html><head></head><body><p>迈威生物董事长、CEO 刘大涛博士首先回顾了公司过去一年取得的成果，从创新研发、资本、商业化等多个维度分析了行业现状，并对迈威生物的发展提出了更高的要求。他强调，<strong>创新药的价值是临床获益、创新突破与全球竞争力的综合体现，同时兼顾经济效率与公共价值</strong>。迈威生物聚焦兼具临床价值与商业价值的创新研发，持续跟踪和参与基础研究前沿，在深刻理解疾病生物学机制的前提下，重点布局具备 First in class 潜力的品种，并实现从学术到工业的创新转化。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5afe7e68fada14688c09394f57c08aca\" tg-width=\"1080\" tg-height=\"720\"></p>\n<p>随后，各团队骨干围绕“价值致远，聚势赋能”的主题，通过追踪行业前沿动态与政策导向、复盘项目实践得失，分享了对创新药研发、产品成果转化和商业化的深刻思考，为公司的未来发展提供了建设性思路。今年，大会新增了 AI 论坛，邀请内外部讲者分享了 AI 在药物开发中的实践案例，并展望 AI 在生物药研发领域广阔前景。大会最后对在知识产权、成果转化、融资及上市项目中做出突出贡献的团队和个人进行了表彰。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4b68c55348fcbe2bd3055929a35cea11\" tg-width=\"1080\" tg-height=\"720\"></p>\n<p>科技大会是迈威生物为推动新药研发及商业转化体系建设、赋能核心骨干，持续提升创新管理水平的年度交流大会。大会促进跨部门经验共享、视野互通，赋能全链条效率提升，为业务创新优化提效提供了全新参考方向。迈威生物始终致力于源头创新，专注于肿瘤与年龄相关性疾病领域，让创新成果切实惠及患者，满足全球更多未被满足的临床需求。</p>\n<p><a href=\"https://laohu8.com/S/02493\">$迈威生物-B(02493)$</a></p></body></html>","text":"迈威生物董事长、CEO 刘大涛博士首先回顾了公司过去一年取得的成果，从创新研发、资本、商业化等多个维度分析了行业现状，并对迈威生物的发展提出了更高的要求。他强调，创新药的价值是临床获益、创新突破与全球竞争力的综合体现，同时兼顾经济效率与公共价值。迈威生物聚焦兼具临床价值与商业价值的创新研发，持续跟踪和参与基础研究前沿，在深刻理解疾病生物学机制的前提下，重点布局具备 First in class 潜力的品种，并实现从学术到工业的创新转化。 随后，各团队骨干围绕“价值致远，聚势赋能”的主题，通过追踪行业前沿动态与政策导向、复盘项目实践得失，分享了对创新药研发、产品成果转化和商业化的深刻思考，为公司的未来发展提供了建设性思路。今年，大会新增了 AI 论坛，邀请内外部讲者分享了 AI 在药物开发中的实践案例，并展望 AI 在生物药研发领域广阔前景。大会最后对在知识产权、成果转化、融资及上市项目中做出突出贡献的团队和个人进行了表彰。 科技大会是迈威生物为推动新药研发及商业转化体系建设、赋能核心骨干，持续提升创新管理水平的年度交流大会。大会促进跨部门经验共享、视野互通，赋能全链条效率提升，为业务创新优化提效提供了全新参考方向。迈威生物始终致力于源头创新，专注于肿瘤与年龄相关性疾病领域，让创新成果切实惠及患者，满足全球更多未被满足的临床需求。 $迈威生物-B(02493)$","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/570521772691696","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["02493","688062"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1075,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":233,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02493","688062"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":75,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/571155827302928"}